Eli Lilly (NYSE: $LLY) reached a $1 trillion market valuation, marking a historic moment for the global health-care industry. The company trades around $1,048 per […]
Category: Drug Manufacturers
AstraZeneca (NASDAQ: $AZN) Releases Q1 Fiscal 2025 Results: Is This Pharma Stock A Great Buy After Its Q1 Results?
AstraZeneca (NASDAQ: $AZN) posted its Q1 2025 earnings on April 29. The stock trades at $70.13. Revenue for the quarter rose 10% year-over-year to $13.59 […]
Johnson & Johnson (NYSE: JNJ) Releases Q1 Fiscal 2025 Results: Is This Dividend Stock Still a Buy Amid Tariff Fears?
Johnson & Johnson (NYSE: $JNJ), a major multinational that produces medical devices and pharmaceuticals, released its first-quarter fiscal 2025 results on Tuesday, April 15, 2025, […]
Alvotech (NASDAQ: ALVO) Releases Q4 Fiscal 2024 Results: Is This Biotech A Buy in 2025?
Alvotech (NASDAQ: $ALVO), a leading global biopharmaceutical manufacturer of biosimilars, released its Q4 fiscal 2024 results on Wednesday, March 26, 2024, after markets closed. Here […]
Gilead Sciences (NASDAQ: GILD) Releases Q4 Fiscal 2024 Earnings: Is The Biotech Giant Still A Great Investment In 2025?
Gilead Sciences (NASDAQ: $GILD) is a biotech giant that develops and sells drugs and invests in public health programs. On Tuesday, February 12, 2025, after […]
Johnson & Johnson (NYSE: JNJ) Posts Earnings Beat In Q4 Fiscal 2024 Results: Here is Why The Stock Dipped
Johnson & Johnson (NYSE: $JNJ) stock remained flat during the Wednesday, January 22, 2025, trading session after exceeding analysts’ expectations in its Q4 results. Johnson […]